PriceTracker GLP-1
Loading the index…

Try

Find the cheapest for me
Loading the index…

Try

GLP-1 TV · Clinician

Where to inject for MAXIMUM GLP-1 Weight Loss | Breaking down the data

Clinician12:41Jan 2025

Today’s cheapest GLP-1$41/mo at Wellmedr, sale price.Compare all GLP-1 prices Price read 13 Nov 2026 from the seller’s own page, ranked by price alone. That price is a compounded drug, and compounded drugs are not FDA-approved. Not from the video’s creator.

Our summary

The speaker, an internal medicine physician in Upstate New York, looks at whether the injection site matters for GLP-1 weight loss and appetite suppression. He reviews the three injection areas named in the prescribing pamphlets for Ozempic, Wegovy, Mounjaro and Zepbound: the abdomen around the navel, the upper thigh and the upper arm. He says he has lost over 140 pounds using GLP-1 therapy and peptides.

Published by Dr. Kevin Joseph, DO on YouTube

As published by the channel. Not medical advice, and not an endorsement.

What else the video covers

He walks through an Eli Lilly study of tirzepatide with 54 participants in three groups of 18, each receiving a 5 mg dose in all three sites across three phases, with a 35 day washout between injections. He calls the small sample a red flag and notes the study did not report whether the differences were clinically significant. According to him, the abdomen showed slightly higher absorption (24% versus 21% for the upper arm and 22% for the thigh) and a slightly higher peak concentration (about 25% versus 23% and 21%). He says abdominal injections were also linked to more nausea and vomiting, and 24% of participants reported decreased appetite with abdominal injections, compared with 13.3% for the upper arm and 5% for the thigh.

He then shares his own experience. After injecting 1.25 mg into the thigh instead of the abdomen, he says he had no appetite suppression for the week and also no side effects, including no constipation. He returned to the abdomen, where appetite suppression came back along with constipation. He now injects 1.25 mg every 5 days. His view is that the best site varies by person, that starting with the abdomen is reasonable for weight loss, that rotating sites may help if side effects are severe, and that once a site works there is no need to keep rotating.

Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.

Takeaways

The main points, in the order they come up. Tap a time to play from there.

  1. 1:32 The speaker lists the three injection sites named in the pamphlets: around the navel, the upper thigh and the upper arm.
  2. 2:02 He describes the Eli Lilly study design: 54 participants in three groups, 5 mg doses, and a 35 day washout, and he calls the sample size very small.
  3. 4:04 He reports the study found slightly higher absorption from the abdomen (24%) than the upper arm (21%) or thigh (22%), with small differences.
  4. 6:37 He says abdominal injections came with more nausea and vomiting and more reported appetite reduction (24%) than the upper arm (13.3%) or thigh (5%).
  5. 8:40 He describes his own switch to the thigh, which gave him no appetite suppression and no side effects, and his return to the abdomen.
  6. 10:40 He recommends starting with the abdomen, rotating if side effects are debilitating, and staying with a site that works.

Key moments

Tap one to play from there.

  1. 0:00 Intro
  2. 0:30 Mechanism of Action
  3. 1:33 Where to inject
  4. 2:37 The study
  5. 4:19 The results
  6. 6:27 Adverse results
  7. 7:27 My personal experience
  8. 10:34 Final thoughts

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Side effects mentioned
nausea, vomiting, constipation, fatigue and low appetite

Questions this video answers

Which injection site is best for GLP-1 weight loss?

The speaker says it varies by person. Based on the raw numbers from the Eli Lilly study, he says the abdomen gave slightly faster absorption and higher blood concentration of tirzepatide. He suggests starting there if weight loss is the goal.

Do you need to rotate GLP-1 injection sites?

According to the speaker, there is no study showing improved weight loss from rotating sites, and he says staying in one location will not cause desensitization. He suggests rotating mainly if side effects are debilitating, and sticking with a site once it works.

Does injecting in the abdomen cause more side effects than the thigh or arm?

The speaker says the Eli Lilly study reported more nausea and vomiting with abdominal injections than with the upper arm or thigh. He also says the abdomen was linked to more reported appetite suppression, so he frames it as a trade-off between the two.

How big was the Eli Lilly injection site study?

The speaker says it had 54 participants split into three groups of 18, each receiving a 5 mg dose in all three sites with a 35 day washout between. He considers this very small compared with trials of a few thousand people.

Videos on the same question

The closest videos in the library by what is said in them, not by title.

Read next

Our guides closest to what this video covers, with prices checked weekly.

  • Where to inject a GLP-1, and the one thing the labels disagree about

    All the weekly GLP-1 injections go into the same three places. The Wegovy label says to inject subcutaneously in the abdomen, thigh or upper arm, rotating sites with each dose, once weekly at any time of day with or without meals. Zepbound's label says the same about the abdomen and thigh but adds something nobody mentions: the back of the upper arm should be injected by another person. If you are on a compounded vial rather than a pen, the task is different again, because you are drawing the dose yourself.

  • GLP-1 vs GLP-2 vs GLP-3: what the names mean, and which ones you can actually buy

    GLP-1 drugs such as semaglutide act on one receptor. "GLP-2" is used online for tirzepatide (Zepbound, Mounjaro), which acts on two, GIP and GLP-1, and "GLP-3" for retatrutide, which adds the glucagon receptor. Neither nickname is the real name: GLP-2 is a separate gut hormone whose drug, Gattex, treats short bowel syndrome. Retatrutide produced 28.3% mean weight loss at 80 weeks in its phase 3 trial but is not FDA-approved; Lilly plans to file in Q1 2027. Tirzepatide is the strongest option you can buy today.

  • GLP-1s before surgery: do you stop Ozempic, Wegovy or Zepbound, and for how long?

    Most people can keep taking a GLP-1 before elective surgery, according to 2024 guidance from five medical societies including the American Society of Anesthesiologists, which replaced its 2023 advice to hold a weekly shot for a week. People at the highest risk (early in dose increases, on a high dose, or with nausea, vomiting or bloating) may be asked to follow a liquid diet for 24 hours, have a stomach ultrasound or wait. Every label says to tell the team you take it.

Next steps

Ozempic prices

Insurance

Find more like it

Side effectsDose changeWeigh-in and resultsFood noise and cravingsInjection techniqueHow it worksThe trialsNauseaVomitingConstipation

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV